ChitogenX Inc. announced the launch of its second orthopedic development program in meniscus repair following the development completion of its preclinical arthroscopic surgery program.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | -.--% | -.--% | -53.85% |
05-27 | ChitogenX Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 | CI |
02-28 | Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-53.85% | 1.83M | |
+50.74% | 54.63B | |
-5.90% | 39.92B | |
+36.87% | 38.82B | |
+14.77% | 26.86B | |
-11.17% | 26.22B | |
-21.69% | 18.78B | |
+26.76% | 12.21B | |
+1.35% | 12.16B | |
+28.21% | 11.94B |
- Stock Market
- Equities
- CHGX Stock
- News ChitogenX Inc.
- ChitogenX Inc. Launches Second Orthopedic Development Program in Meniscus Repair